Unknown

Dataset Information

0

T-Cell-Specific Loss of the PI-3-Kinase p110? Catalytic Subunit Results in Enhanced Cytokine Production and Antitumor Response.


ABSTRACT: Class IA phosphatidylinositol 3-kinase (PI3K) catalytic subunits p110? and p110? are targets in cancer therapy expressed at high levels in T lymphocytes. The role of p110? PI3K in normal or pathological immune responses is well established, yet the importance of p110? subunits in T cell-dependent immune responses is not clear. To address this problem, mice with p110? conditionally deleted in CD4+ and CD8+ T lymphocytes (p110?-/-?T) were used. p110?-/-?T mice show normal development of T cell subsets, but slightly reduced numbers of CD4+ T cells in the spleen. "In vitro," TCR/CD3 plus CD28 activation of naive CD4+ and CD8+ p110?-/-?T T cells showed enhanced effector function, particularly IFN-? secretion, T-bet induction, and Akt, Erk, or P38 activation. Tfh derived from p110?-/-?T cells also have enhanced responses when compared to normal mice, and IL-2 expanded p110?-/-?T CD8+ T cells had enhanced levels of LAMP-1 and Granzyme B. By contrast, the expansion of p110?-/-?T iTreg cells was diminished. Also, p110?-/-?T mice had enhanced anti-keyhole limpet hemocyanin (KLH) IFN-?, or IL-4 responses and IgG1 and IgG2b anti-KLH antibodies, using CFA or Alum as adjuvant, respectively. When compared to WT mice, p110?-/-?T mice inoculated with B16.F10 melanoma showed delayed tumor progression. The percentage of CD8+ T lymphocytes was higher and the percentage of Treg cells lower in the spleen of tumor-bearing p110?-/-?T mice. Also, IFN-? production in tumor antigen-activated spleen cells was enhanced. Thus, PI3K p110? plays a significant role in antigen activation and differentiation of CD4+ and CD8+ T lymphocytes modulating antitumor immunity.

SUBMITTER: Aragoneses-Fenoll L 

PROVIDER: S-EPMC5835342 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

T-Cell-Specific Loss of the PI-3-Kinase p110α Catalytic Subunit Results in Enhanced Cytokine Production and Antitumor Response.

Aragoneses-Fenoll Laura L   Ojeda Gloria G   Montes-Casado María M   Acosta-Ampudia Yeny Y   Dianzani Umberto U   Portolés Pilar P   Rojo José M JM  

Frontiers in immunology 20180227


Class IA phosphatidylinositol 3-kinase (PI3K) catalytic subunits p110α and p110δ are targets in cancer therapy expressed at high levels in T lymphocytes. The role of p110δ PI3K in normal or pathological immune responses is well established, yet the importance of p110α subunits in T cell-dependent immune responses is not clear. To address this problem, mice with p110α conditionally deleted in CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes (p110α<sup>-/-</sup>ΔT) were used. p110α<sup>-/-</sup>Δ  ...[more]

Similar Datasets

| S-EPMC4209962 | biostudies-literature
| S-EPMC3865866 | biostudies-literature
| S-EPMC2734096 | biostudies-literature
| S-EPMC4426038 | biostudies-literature
| S-EPMC8232790 | biostudies-literature
| S-EPMC4219313 | biostudies-literature
| S-EPMC4130797 | biostudies-literature
2010-12-31 | E-GEOD-23826 | biostudies-arrayexpress
| S-EPMC3731339 | biostudies-literature
| S-EPMC3017722 | biostudies-literature